Area of research
Physiology · Immunology and Allergy
Research interest
Research interests include Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, Food Allergy and Anaphylaxis Research, and Chronic Obstructive Pulmonary Disease (COPD) Research.
Adherence to Treatment in Allergic Rhinitis During the Pollen Season in Europe: A MASK‐air Study
Allergic Rhinitis and Its Impact on Asthma ( <scp>ARIA</scp> )‐ <scp>EAACI</scp> Guidelines—2024–2025 Revision: Part I—Guidelines on Intranasal Treatments
Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma ( <scp>ARIA</scp> )‐EAACI 2024–2025 Guidelines: From Evidence‐to‐Decision Frameworks to Digitalised Shared Decision‐Making Algorithms
Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users
Comparison of Allergic Rhinitis Treatments on Patient Satisfaction: A <scp>MASK</scp> ‐air and <scp>EAACI</scp> Methodological Committee Report
Impact of allergic symptoms on work productivity in allergic rhinitis: A MASK-air direct patient data study
Assessment of the Effectiveness of Allergic Rhinitis Medications Using a Target Trial Emulation Approach Based on Mobile Health Data
Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study
Asthma and rhinitis control in adolescents and young adults: A real‐world <scp>MASK</scp> ‐air study
Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air<sup>®</sup>
Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK‐air study
Rhinitis associated with asthma is distinct from rhinitis alone: The <scp>ARIA‐MeDALL</scp> hypothesis
Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air<sup>®</sup>approach
Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The <scp>ARIA‐EAACI</scp> approach – ARIA‐EAACI Task Force Report
Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study
Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study
MASK‐air<sup>®</sup> real‐world data in respiratory allergy in old‐age adults
<scp>MASK</scp>‐air® direct patient data support the <scp>ARIA‐MeDALL</scp> hypothesis on allergic phenotypes
Asthma hospitalizations: A call for a national strategy to fight health inequities
Improvement of daily allergy control by sublingual immunotherapy: A <scp>MASK</scp>‐air® study
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK‐air<sup>®</sup> real‐world data
The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis
Academic Productivity of Young People With Allergic Rhinitis: A MASK-air Study
Alpine altitude climate treatment for severe and uncontrolled asthma: An EAACI position paper
Real‐world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities
Comparison of rhinitis treatments using <scp>MASK</scp>‐air® data and considering the minimal important difference
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The <scp>MASK</scp>‐air® longitudinal study
Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app
Anaphylaxis in elderly people
Cutoff Values of MASK-air Patient-Reported Outcome Measures